Correction

Published on 28 Nov 2023

Corrigendum: Risk and prediction of multiple primary malignancies after early gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Na Chen
Lei Shi
Jian Ge
Ruzhen Jia
Junmei Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1298412

476 views

Original Research

Published on 17 Nov 2023

Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Verena Maria Raters
Florian Gebauer
Heike Löser
Wolfgang Schröder
Hans Anton Schlösser
Hans Fuchs
Christiane Bruns
Alexander Quaas
Thomas Zander

Frontiers in Oncology

doi 10.3389/fonc.2023.1249172

1,063 views
2 citations

Case Report

Published on 09 Nov 2023

Case Report: a rare primary gastric choriocarcinoma revealed on 18F-FDG PET/CT

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yi Zhao
Wei Diao
Suping Li
Mengxi Yang
Zhuzhong Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1227236

1,266 views

Case Report

Published on 08 Nov 2023

Gastroblastoma in a 5-year-old child: a case report and literature review

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Jizhen Feng
Chunxiang Ling
Yingjie Xue
Jiamei Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1198762

1,080 views
2 citations

Case Report

Published on 03 Nov 2023

Advanced gastric cancer with metachronous intracranial oligometastases without recurrence after multidisciplinary team discussion and comprehensive treatment: a case report

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Lijuan Shao
Hongyu Zhang
Wenting He
Jun Wu
Danxia Zhu
Haibo Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1268199

1,571 views

Original Research

Published on 31 Oct 2023

Cost-effectiveness of analysis serplulimab plus chemotherapy as first-line therapy for PD-L1-positive advanced esophageal squamous cell carcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Hanrui Zheng
Jiafeng Li
Feng Wen
Na Su

Frontiers in Oncology

doi 10.3389/fonc.2023.1216960

1,092 views
1 citation

Original Research

Published on 30 Oct 2023

Risk stratification of gastric cancer screening in community population based on oral contrast-enhanced ultrasonography examination: A 3-year follow-up analysis report

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Sainan Guan
Ronghua Yan
Xiaomin Chen
Weiqiang Chen
Xi Zhou
Minghui Zhou
Zhengneng Xie
Wen Tan
Yongyan He
Juan Fu

Frontiers in Oncology

doi 10.3389/fonc.2023.1218800

1,127 views

Editorial

Published on 26 Oct 2023

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Jun Huang
Qun Zhang
GuangZhao Pan
Xin Hu
Dongshi Chen
Kui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1276414

1,370 views
1 citation

Methods

Published on 24 Oct 2023

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Andrea Alberti
Gertraud Stocker
Florian Lordick
Ulrich T. Hacker
Benjamin Kobitzsch
Ivonne Haffner
Gian Luca Baiocchi
Manuel Zamparini
Guido A. M. Tiberio
Carla Baronchelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1276138

1,374 views

Review

Published on 24 Oct 2023

The central role of gastrin in gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Helge Waldum
Patricia Mjønes

Frontiers in Oncology

doi 10.3389/fonc.2023.1176673

3,541 views
5 citations

Systematic Review

Published on 23 Oct 2023

Diagnostic performance of CT scan–based radiomics for prediction of lymph node metastasis in gastric cancer: a systematic review and meta-analysis

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zanyar HajiEsmailPoor
Peyman Tabnak
Behzad Baradaran
Fariba Pashazadeh
Leili Aghebati-Maleki

Frontiers in Oncology

doi 10.3389/fonc.2023.1185663

2,770 views
6 citations

Review

Published on 20 Oct 2023

Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Mengying Xue
Yusuo Tong
Yaozu Xiong
Changhua Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1257266

2,456 views
3 citations

Systematic Review

Published on 20 Oct 2023

Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Moein Piroozkhah
Ali Aghajani
Pooya Jalali
Arvin Shahmoradi
Mobin Piroozkhah
Younes Tadlili
Zahra Salehi

Frontiers in Oncology

doi 10.3389/fonc.2023.1277265

3,698 views

Clinical Trial

Published on 16 Oct 2023

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Joseph Tintelnot
Alexander Stein
Salah-Eddin Al-Batran
Thomas Ettrich
Thorsten Götze
Barbara Grün
Georg Martin Haag
Vera Heuer
Ralf-Dieter Hofheinz
Nils Homann

Frontiers in Oncology

doi 10.3389/fonc.2023.1272175

3,094 views
4 citations

Original Research

Published on 10 Oct 2023

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Xianyan Chen
Yingjie Zhang
Xiaojuan Zhou
Min Wang
Feifei Na
Lin Zhou
Yong Xu
Bingwen Zou
Jianxin Xue
Yongmei Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1274924

1,627 views
2 citations

Original Research

Published on 09 Oct 2023

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhanpeng Liang
Liwen Liu
Wenxia Li
Huiqin Lai
Luzhen Li
Jiaming Wu
Huatang Zhang
Cantu Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1258347

6,633 views
3 citations

Navigation group

Articles

Corrigendum: Risk and prediction of multiple primary malignancies after early gastric cancer

Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma

Case Report: a rare primary gastric choriocarcinoma revealed on 18F-FDG PET/CT

Gastroblastoma in a 5-year-old child: a case report and literature review

Advanced gastric cancer with metachronous intracranial oligometastases without recurrence after multidisciplinary team discussion and comprehensive treatment: a case report

Cost-effectiveness of analysis serplulimab plus chemotherapy as first-line therapy for PD-L1-positive advanced esophageal squamous cell carcinoma

Risk stratification of gastric cancer screening in community population based on oral contrast-enhanced ultrasonography examination: A 3-year follow-up analysis report

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

The central role of gastrin in gastric cancer

Diagnostic performance of CT scan–based radiomics for prediction of lymph node metastasis in gastric cancer: a systematic review and meta-analysis

Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma

Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials